Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Dec 27, 2011

Mylan Receives Approval for First-to-File Generic Keppra XR® Extended-Release Tablets

Dec 20, 2011

Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment

Dec 16, 2011

Mylan Launches Generic Version of Toprol-XL® Tablets

Dec 12, 2011

Mylan Names John Thievon President of Dey Pharma

Dec 02, 2011

Mylan Launches Generic Version of Cyklokapron® Injection

Dec 01, 2011

Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS

Dec 01, 2011

Mylan Confirms First-to-File Patent Challenge Relating to Generess™ Fe

Dec 01, 2011

Mylan Launches Generic Version of Caduet® Tablets

Dec 01, 2011

Mylan Committed to Expanding Access in Developing Countries to High Quality, Affordable HIV/AIDS Treatment

Nov 28, 2011

Mylan Receives Approval for Generic Version of Zinecard® for Injection

Pagination

First page
Previous page
…
Page 65
Page 66
Page 67
Page 68
Current page 69
Page 70
Page 71
Page 72
Page 73
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.